Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Pasmans, HellaSchurink-Van't Klooster, Tessa M
Bogaard, Marjan J M
van Rooijen, Debbie M
de Melker, Hester E
Welters, Marij J P
van der Burg, Sjoerd H
van der Klis, Fiona R M
Buisman, Anne-Marie
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls.Published in
Vaccine 2019; advance online publication (ahead of print)PMID
31575492ae974a485f413a2113503eed53cd6c53
10.1016/j.vaccine.2019.09.066
Scopus Count
Collections
Related articles
- Persistence of immune response following bivalent HPV vaccination: A follow-up study among girls routinely vaccinated with a two-dose schedule.
- Authors: Schurink-van 't Klooster TM, Donken R, Schepp RM, van der Klis FRM, de Melker HE
- Issue date: 2018 Nov 26
- Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine.
- Authors: Godi A, Bissett SL, Miller E, Beddows S
- Issue date: 2015
- Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial.
- Authors: Leung TF, Liu AP, Lim FS, Thollot F, Oh HM, Lee BW, Rombo L, Tan NC, Rouzier R, Friel D, De Muynck B, De Simoni S, Suryakiran P, Hezareh M, Folschweiller N, Thomas F, Struyf F
- Issue date: 2015
- Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination.
- Authors: Lazcano-Ponce E, Torres-Ibarra L, Cruz-Valdez A, Salmerón J, Barrientos-Gutiérrez T, Prado-Galbarro J, Stanley M, Muñoz N, Herrero R, Hernández-Ávila M
- Issue date: 2019 Jan 1
- Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study.
- Authors: Sankaranarayanan R, Joshi S, Muwonge R, Esmy PO, Basu P, Prabhu P, Bhatla N, Nene BM, Shaw J, Poli URR, Verma Y, Zomawia E, Pimple S, Tommasino M, Pawlita M, Gheit T, Waterboer T, Sehr P, Pillai MR, Indian HPV vaccine study group
- Issue date: 2018 Aug 6